Back to LBRX

GOLDMAN SACHS GROUP INC → LBRX

GOLDMAN SACHS GROUP INC LBRX Position History

LB Pharmaceuticals Inc • Healthcare

Quarters held
8
Latest value
$814K
Q3 2026
Peak value
$36.2M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$5.4M
Q4 2025$6.7M
Q4 2025$6.7M
Q1 2026$9M
Q2 2026$18.3M
Q2 2026$365K
Q3 2026$36.2M
Q3 2026$814K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$814K21.2K——
Q3 2026$36.2M943.2K——
Q2 2026$365K11.2K——
Q2 2026$18.3M565.2K——
Q1 2026$9M363.8K——
Q4 2025$6.7M303.1K——
Q4 2025$6.7M303.1K——
Q3 2025$5.4M343.5K——

Other funds holding LBRX

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B